<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">toxsci</journal-id>
<journal-title-group>
<journal-title>Toxicological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-6080</issn>
<issn pub-type="epub">1096-0929</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30169818</article-id>
<article-id pub-id-type="pmc">6317428</article-id>
<article-id pub-id-type="doi">10.1093/toxsci/kfy218</article-id>
<article-id pub-id-type="publisher-id">kfy218</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>NTP NEUROTOXICOLOGY SCREENING STRATEGIES INITIATIVE</subject>
<subj-group subj-group-type="category-toc-heading">
<subject>NTP NEUROTOX: HUMAN iPSC NEURAL CULTURES</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sirenko</surname>
<given-names>Oksana</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff1">1</xref>
<xref ref-type="corresp" rid="kfy218-cor1"></xref>
<!--<email>oksana.sirenko@moldev.com</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parham</surname>
<given-names>Frederick</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dea</surname>
<given-names>Steven</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sodhi</surname>
<given-names>Neha</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Biesmans</surname>
<given-names>Steven</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mora-Castilla</surname>
<given-names>Sergio</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ryan</surname>
<given-names>Kristen</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Behl</surname>
<given-names>Mamta</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chandy</surname>
<given-names>Grischa</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crittenden</surname>
<given-names>Carole</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vargas-Hurlston</surname>
<given-names>Sarah</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guicherit</surname>
<given-names>Oivin</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gordon</surname>
<given-names>Ryan</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6985-4221</contrib-id>
<name>
<surname>Zanella</surname>
<given-names>Fabian</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carromeu</surname>
<given-names>Cassiano</given-names>
</name>
<xref ref-type="aff" rid="kfy218-aff3">3</xref>
<xref ref-type="corresp" rid="kfy218-cor1"></xref>
<!--<email>cassiano.carromeu@stemonix.com</email>-->
</contrib>
</contrib-group>
<aff id="kfy218-aff1"><label>1</label>Molecular Devices LLC, San Jose, California 95134</aff>
<aff id="kfy218-aff2"><label>2</label>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina</aff>
<aff id="kfy218-aff3"><label>3</label>StemoniX, Inc, Maple Grove, Minnesota 55311</aff>
<author-notes>
<corresp id="kfy218-cor1">To whom correspondence should be addressed at 3860 N First Street, San Jose, CA 95134 1.408.548.6051. E-mail: <email>oksana.sirenko@moldev.com</email> and E-mail: <email>cassiano.carromeu@stemonix.com</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2018-08-31" pub-type="epub">
<day>31</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>167</volume>
<issue>1</issue>
<fpage>58</fpage>
<lpage>76</lpage>
<permissions>
<copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="kfy218.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Neurological disorders affect millions of people worldwide and appear to be on the rise. Whereas the reason for this increase remains unknown, environmental factors are a suspected contributor. Hence, there is an urgent need to develop more complex, biologically relevant, and predictive <italic>in vitro</italic> assays to screen larger sets of compounds with the potential for neurotoxicity. Here, we employed a human induced pluripotent stem cell (iPSC)-based 3D neural platform composed of mature cortical neurons and astrocytes as a model for this purpose. The iPSC-derived human 3D cortical neuron/astrocyte co-cultures (3D neural cultures) present spontaneous synchronized, readily detectable calcium oscillations. This advanced neural platform was optimized for high-throughput screening in 384-well plates and displays highly consistent, functional performance across different wells and plates. Characterization of oscillation profiles in 3D neural cultures was performed through multi-parametric analysis that included the calcium oscillation rate and peak width, amplitude, and waveform irregularities. Cellular and mitochondrial toxicity were assessed by high-content imaging. For assay characterization, we used a set of neuromodulators with known mechanisms of action. We then explored the neurotoxic profile of a library of 87 compounds that included pharmaceutical drugs, pesticides, flame retardants, and other chemicals. Our results demonstrated that 57% of the tested compounds exhibited effects in the assay. The compounds were then ranked according to their effective concentrations based on <italic>in vitro</italic> activity. Our results show that a human iPSC-derived 3D neural culture assay platform is a promising biologically relevant tool to assess the neurotoxic potential of drugs and environmental toxicants.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>3D neural cultures</kwd>
<kwd>calcium oscillations</kwd>
<kwd>neurotoxicity</kwd>
<kwd>flame retardants</kwd>
<kwd>pesticides</kwd>
<kwd>polyaromatic hydrocarbons</kwd>
<kwd>iPSC</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Molecular Devices, LLC</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">StemoniX Co</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Environmental Health Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100000066</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="19"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>